Results 231 to 240 of about 838,557 (301)

More Than a Question of Correlation: Characterization of the Evidentiary Basis for Biomarker Surrogates Used in European Marketing Authorizations

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Traditionally, clinical outcomes measuring how a patient feels, functions, or survives are preferred endpoints in clinical trials; however, some may take a long time to manifest in slowly developing diseases. Biomarkers, if properly validated, can serve as surrogate endpoints, acting as substitutes for clinical outcomes.
Renske Johanna Grupstra   +4 more
wiley   +1 more source

Efficacy and safety of ropeginterferon alfa-2b in the treatment of polycythemia vera: a systematic review with single arm meta-analysis. [PDF]

open access: yesAnn Hematol
Nada EA   +10 more
europepmc   +1 more source

Phenotype and genotype of hypophosphatasia cases in Saudi Arabia: multi-center case cohort. [PDF]

open access: yesFront Genet
Alsagheir A   +12 more
europepmc   +1 more source

Rarely listed essential medicines in 158 national lists. [PDF]

open access: yesJ Pharm Policy Pract
Ul Haq MZ   +4 more
europepmc   +1 more source

The quadruple immunotherapy for colorectal cancer (QuICC) trial for mismatch repair-proficient metastatic colorectal cancer. [PDF]

open access: yesOncologist
Bracken-Clarke D   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy